XML 59 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Significant Accounting Policies Summary of Significant Accounting Principles (Tables)
 12 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule of Other Nonoperating Income (Expense)
The following table summarizes the components of other income, net.
 Year Ended June 30,
202420232022
Gains on derivatives not designated as hedging instruments (1)$3,915 $3,311 $58,148 
Currency-related (losses) gains, net (2)(2,818)16,350 244 
Other gains (losses)486 (1,163)3,071 
Total other income, net$1,583 $18,498 $61,463 
_____________________
(1) Includes realized and unrealized gains and losses on derivative currency forward and option contracts not designated as hedging instruments, as well as the ineffective portion of certain interest rate swap contracts that have been de-designated from hedge accounting. For contracts not designated as hedging instruments, we realized (losses) gains of ($1,078), $39,133 and $9,955, respectively, for the fiscal years ended June 30, 2024, 2023 and 2022. Refer to Note 4 for additional details relating to our derivative contracts.
(2) Currency-related (losses) gains, net primarily relates to significant non-functional currency intercompany financing relationships that we may change at times and are subject to currency exchange rate volatility. In addition, during all fiscal years presented, we had certain cross-currency swaps designated as cash flow hedges, which hedge the remeasurement of certain intercompany loans; refer to Note 4 for additional details relating to these cash flow hedges.
Schedule of Weighted Average Number of Shares
The following table sets forth the reconciliation of the weighted-average number of ordinary shares.
 Year Ended June 30,
 202420232022
Weighted average shares outstanding, basic26,151,968 26,252,860 26,094,842 
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/PSUs/warrants (1)
852,719 — — 
Shares used in computing diluted net income (loss) per share attributable to Cimpress plc27,004,687 26,252,860 26,094,842 
Weighted average anti-dilutive shares excluded from diluted net income (loss) per share attributable to Cimpress plc (1)(2)96,207 2,834,351 762,086 
___________________
(1) In the periods in which a net loss is recognized, the impact of share options, PSUs, RSUs and warrants is excluded from shares used in computed diluted net income (loss) per share as it is anti-dilutive. Any equity awards that have a performance condition are not included in dilutive or anti-dilutive shares until the performance condition would have been met as of the end of the reporting period.
(2) On May 1, 2020, we entered into a financing arrangement, which included 7-year warrants to purchase 1,055,377 of our ordinary shares with a strike price of $60 that have a potentially dilutive impact on our weighted average shares outstanding. For the years ended June 30, 2024 and 2022, the average market price of our ordinary shares was higher than the strike price of the warrants. The weighted average dilutive effect of the warrants was 220,668 for the year ended June 30, 2024 and for the year ended June 30, 2022, due to our net loss position, 138,088 outstanding warrants were considered anti-dilutive. For the year ended June 30, 2023, the average share price was below the strike price for the full fiscal year; therefore, the total 1,055,377 outstanding warrants were considered anti-dilutive.